J Neurosci Methods, 2011 · DOI: 10.1016/j.jneumeth.2011.05.007 · Published: August 15, 2011
The enzyme chondroitinase ABC (ChABC) can break down scar tissue after spinal cord injury, helping axons to regrow. Delivering ChABC continuously is difficult, so the researchers used a lentiviral vector (LV) to deliver the gene for ChABC. They created a lentiviral vector (Chase/LV) that encodes chondroitinase AC (Chase) and a green fluorescent protein (GFP) reporter. This allows them to track which cells are producing the enzyme. The study showed that cells infected with Chase/LV produced the enzyme, which broke down CSPGs and promoted axon growth in lab dishes and in the spinal cords of rats.
Chase/LV vector can be used as a gene therapy tool to deliver chondroitinase to the site of injury in the CNS.
The use of Chase/LV can reduce scar inhibition by degrading CSPGs, promoting axonal growth and repair.
Chase/LV allows for sustained and controlled delivery of the enzyme, overcoming the limitations of direct enzyme injection.